Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 20, 2026BiomedicinesOpen Access

Recent Advances in the Diagnosis and Management of Clinically Significant Portal Hypertension in Liver Cirrhosis: A Clinical Review

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJan Christoph SchumacherUniversity of CologneJLJ LeutigerUniversity of CologneAMAnna MartinUniversity of Cologne

Discussion

Loading...

Member takes

Implication

Clinical review highlights improved diagnosis and management of portal hypertension in liver cirrhosis, suggesting better outcomes.

Key Points

  • This review aims to detail advancements in diagnosing and managing clinically significant portal hypertension in patients with liver cirrhosis.
  • Comprehensive clinical review of diagnostic methods including invasive and non-invasive techniques.
  • Evaluation of risk prediction models like NICER and ANTICIPATE that utilize liver and spleen stiffness and biomarkers.
  • Discussion of current drug management strategies, specifically non-selective beta blockers for CSPH.
  • Recent non-invasive methods effectively identify patients at risk for hepatic decompensation.
  • Non-selective beta blockers are established as an important treatment but highlight a need for strategies targeting patients who do not respond effectively.
  • This review outlines emerging potential treatment options and updated management strategies to enhance patient outcomes.

Cite This Study

Schumacher et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4ee2f03e14405aa9a155https://doi.org/10.3390/biomedicines14051133
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Beneficial effects of carvedilol modulating potassium channels on the control of glucose2022 · 9 citations
  2. 2Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient2024 · 45 citations
  3. 3Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease2025 · 4 citations
  4. 4Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation2023 · 16 citations